First Tracks Biotherapeutics Inc (TRAX) Price Prediction & Forecast

$45.470

+2.083 (+4.58%)At close

Price Predictions

1-Day Price Prediction

+0.74%

1-Week Prediction

+7.58%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

Open in app to unlock longer-horizon forecasts.

Loading chart…

TRAX Prediction & Forecast by Similar Chart Analysis

Alphio's TRAX stock price prediction model matches the current First Tracks Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $45.81 (+0.74%). The 1-week path is $48.92 (+7.58%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy First Tracks Biotherapeutics Inc Stock?

First Tracks Biotherapeutics (TRAX) is a good buy right now due to its current price of $44.05, which is significantly below the analyst price targets of $70 and $50, indicating substantial upside potential. The stock has shown strong momentum with a 5-day change of +27.83% and a year-to-date change of +95.69%. However, the main risk is its negative earnings per share (EPS) of -0.95 reported for the last quarter, which reflects ongoing financial challenges.

TRAX stock price ended at $45.47 on Tuesday, after rising +4.58%

First Tracks Biotherapeutics Inc (TRAX) last closed at $45.4700012, gaining +4.58%. These facts feed the 1-day and 1-week TRAX price prediction above.